Methylcobalamin Injection 1500 mcg (Methylcobalamin)

Product Overview

Methylcobalamin Injection 1500 mcg is a sterile, pharmaceutical‑grade solution of methylcobalamin, the biologically active form of vitamin B12, supplied by Leeford Pharma Pvt Ltd. The product is packaged in 2 ml glass ampoules, each containing a precise 1500 microgram dose of the active ingredient. Pack sizes are available in 10, 20 or 30 ampoules, offering flexibility for both short‑term and maintenance therapy. The ampoules are sealed under nitrogen to preserve stability and are labeled with an expiration date that meets regulatory standards. This medication falls under the Nutrition Care therapeutic class and is intended for the management of documented vitamin B12 deficiency in adult patients.

What is Methylcobalamin Injection 1500 mcg (Methylcobalamin)

Vitamin B12, also known as cobalamin, is essential for numerous metabolic processes, including DNA synthesis, red blood cell formation and the maintenance of healthy nerve tissue. Methylcobalamin is one of two active coenzyme forms of B12 that the body can use directly, the other being adenosylcobalamin. Because it does not require hepatic conversion, methylcobalamin is absorbed efficiently and can cross cell membranes more readily than other B12 derivatives. The 1500 mcg strength represents a high pharmacologic dose that is commonly employed in clinical practice to rapidly replenish depleted body stores, especially in patients with severe deficiency, malabsorption syndromes, or those undergoing long‑term metformin treatment. The injectable route bypasses gastrointestinal barriers, ensuring consistent bioavailability regardless of gut health.

Uses and Benefits

The primary therapeutic use of Methylcobalamin Injection 1500 mcg is the correction of vitamin B12 deficiency, a condition that can arise from inadequate dietary intake, pernicious anemia, gastric surgery, chronic use of proton‑pump inhibitors or certain anticonvulsants. Clinical benefits include restoration of normal serum B12 levels, reduction of homocysteine concentrations, improvement in energy levels, and alleviation of neurologic symptoms such as paresthesia, gait disturbances and cognitive fog. Regular supplementation may also support cardiovascular health by lowering homocysteine, a known risk factor for endothelial dysfunction. In patients with malabsorption, the injectable form provides a reliable method of delivery that does not depend on intrinsic factor or pancreatic function. Additionally, some clinicians use methylcobalamin as an adjunct in the management of diabetic neuropathy, although evidence is supportive rather than definitive.

How It Works

Once administered, methylcobalamin enters cells and participates directly in two pivotal enzymatic reactions. First, it acts as a cofactor for methionine synthase, facilitating the conversion of homocysteine to methionine, a process that also regenerates tetrahydrofolate for one‑carbon metabolism. Second, it serves as a cofactor for methylmalonyl‑CoA mutase, enabling the conversion of methylmalonyl‑CoA to succinyl‑CoA, a step critical for fatty acid synthesis and the production of myelin sheaths surrounding nerves. By restoring these pathways, methylcobalamin helps maintain normal myelin integrity, supports neurotransmitter synthesis and contributes to healthy homocysteine metabolism. The rapid onset of action after injection is attributed to the high dosage and direct delivery into the bloodstream, making it a preferred option for patients requiring swift correction of deficiency.

Dosage Guidelines

Dosage of Methylcobalamin Injection 1500 mcg must be individualized and prescribed by a qualified healthcare professional. A typical initial regimen involves the administration of one ampoule via intramuscular or subcutaneous injection once weekly for four to six weeks, depending on the severity of depletion and clinical response. Following this induction phase, maintenance dosing is usually reduced to one ampoule every one to three months, with the exact interval determined by repeat serum B12 measurements and symptom assessment. Laboratory monitoring is recommended at baseline and after each treatment cycle to evaluate efficacy and adjust dosing as needed. Patients should be instructed to report any missed doses to their clinician and not to double‑dose to compensate. For detailed dosing algorithms, refer to reputable sources such as the NIH Office of Dietary Supplements here or Drugs.com here.

Side Effects

Adverse reactions to methylcobalamin are generally mild and transient. The most frequently reported side effects include localized pain, erythema or induration at the injection site, as well as occasional headache, dizziness or nausea. These events typically resolve without intervention. Rarely, patients may experience hypersensitivity reactions that can manifest as skin rash, pruritus or, in severe cases, anaphylaxis. Immediate medical attention is required if symptoms such as swelling of the face or throat, difficulty breathing, or cardiac arrhythmias develop. Reporting of any adverse event to a healthcare provider ensures proper documentation and contributes to ongoing safety surveillance. The overall safety profile of methylcobalamin is considered favorable when used according to clinical guidelines.

Warnings and Precautions

Methylcobalamin Injection 1500 mcg should not be used in individuals with a known hypersensitivity to vitamin B12 or any excipients present in the formulation. Caution is advised in patients with severe renal impairment, as impaired clearance may necessitate dose adjustments. Although animal studies have not indicated teratogenic effects, pregnant or lactating women should only receive the medication under the supervision of a physician. The product must be stored at controlled room temperature, protected from light, and kept out of reach of children. Prior to initiation, a comprehensive medical history should be obtained, focusing on current medications, especially those that may interact with folate metabolism such as methotrexate or pyrimethamine. Concomitant use with other B‑vitamin supplements is generally safe but should be coordinated with a healthcare professional to avoid unnecessary duplication.

FAQs

What condition does Methylcobalamin Injection 1500 mcg treat?

It is indicated for the treatment of vitamin B12 deficiency, including cases related to dietary insufficiency, pernicious anemia, malabsorption syndromes or medication‑induced depletion.

How often should the injection be administered?

The dosing schedule is individualized; a common protocol involves weekly injections for four to six weeks followed by maintenance doses every one to three months, as determined by a clinician.

Can the injection be self‑administered at home?

Self‑administration is possible only after proper training and under the supervision of a healthcare professional. Patients must follow sterile technique and storage recommendations.

Are there any dietary restrictions while using this medication?

No specific dietary restrictions are required, but maintaining a balanced diet that includes animal proteins and fortified foods can support overall nutritional status.

Where can I find more scientific information about vitamin B12?

Comprehensive details are available from the NIH Office of Dietary Supplements here and the U.S. Food and Drug Administration’s dietary supplement resources.

Related Products

• Walcobal 1500mcg Injection
• Potassium Citrate 5 mg (Generic)
• Vitamin C 150mg Inj (Ascorbic Acid)
• Bigfun (Sildenafil Citrate)
• Bigfun 100 mg (Sildenafil Citrate)
• Bigfun 50 mg (Sildenafil Citrate)
• Ascorbic Acid 50 ml (Vitamin C) (Ascorbic Acid)
• Beplex Forte Plus 11 ml Injection (Vitamin B-Complex)
• Alpha D3 0.25 mcg (Alfacalcidol)
• Kenadion Injection (Phytomenadione)
• Potrate (Potassium Citrate)
• Kenadion Injection 0.5 ml (Phytomenadione)